Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Other Operating Expenses: 2020-2025

Historic Other Operating Expenses for iSpecimen (ISPC) over the last 6 years, with Sep 2025 value amounting to $1.5 million.

  • iSpecimen's Other Operating Expenses fell 44.05% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year decrease of 25.37%. This contributed to the annual value of $12.4 million for FY2024, which is 7.12% up from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Other Operating Expenses is $1.5 million, which was up 44.94% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Other Operating Expenses ranged from a high of $4.3 million in Q4 2024 and a low of $1.0 million during Q2 2025.
  • In the last 3 years, iSpecimen's Other Operating Expenses had a median value of $2.7 million in 2024 and averaged $2.5 million.
  • Per our database at Business Quant, iSpecimen's Other Operating Expenses soared by 78.34% in 2021 and then crashed by 65.89% in 2025.
  • iSpecimen's Other Operating Expenses (Quarterly) stood at $2.6 million in 2021, then increased by 19.48% to $3.1 million in 2022, then increased by 0.49% to $3.1 million in 2023, then skyrocketed by 41.88% to $4.3 million in 2024, then slumped by 44.05% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $1.0 million for Q2 2025, and $1.4 million during Q1 2025.